KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $1,123,000 | +7.2% | 30,000 | 0.0% | 0.12% | -15.8% |
Q3 2014 | $1,048,000 | -25.0% | 30,000 | 0.0% | 0.15% | -23.2% |
Q2 2014 | $1,397,000 | -33.3% | 30,000 | -55.8% | 0.19% | -41.5% |
Q1 2014 | $2,094,000 | +208.8% | 67,800 | +129.1% | 0.32% | +55.5% |
Q4 2013 | $678,000 | – | 29,600 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |